Begonia: Fully-owned subsidiary's innovative drug APH03867 tablet has been accepted for clinical trial registration application.

Announcement: The drug clinical trial application for the innovative drug APH03867 tablets independently developed by Guangzhou Yipin Red Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Yipin Hong, has been accepted by the China National Medical Products Administration, and has received the "Acceptance Notice".